Detail akcie HBM Healthcare N online

Business Summary: HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, diagnostics, as well as medical technology sectors. The Company focuses on unlisted companies, with two-thirds of assets being invested in private companies that offer high value-creation potential. As a holding company, it is involved in the acquisition, disposal and management of a diversified portfolio, as well as in financing and supporting the portfolio firms as a key partner. It focuses on companies with products either at an advanced stage of development or already available on the market. The primary investment areas are Western Europe and the United States. The Company's portfolio includes approximately 25 companies. As of March 31, 2012, the Company had six wholly owned subsidiaries, including three subsidiaries on Cayman Islands, two Barbados-based subsidiaries and a subsidiary in the United States.
Financial Summary: BRIEF: For the fiscal year ended 31 March 2025, HBM Healthcare Investments AG revenues increased 81% to SF42M. Net income totaled SF18.5M vs. loss of SF1.1M. Revenues reflect Changes in unrealised gains / losses increase of 36% to -SF47.1M, Realised losses increase of 25% to -SF50.3M, Gains from currency hedging transactions increase from SF0K to SF5.1M. Net Income reflects Financial expenses decrease of 22% to SF1.3M (expense).